Breastfeeding support may cut diabetes risk after pregnancy

NCT ID NCT07176793

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 26 times

Summary

This study aims to develop a better system to support breastfeeding for women who had gestational diabetes, with the goal of preventing type 2 diabetes later. Researchers will work with patients, healthcare providers, and hospital leaders to design a practical strategy. Only 10 participants are involved in this early planning phase.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UC Davis Medical Center

    RECRUITING

    Sacramento, California, 95817, United States

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

breastfeeding support strategy

What this could lead to

If successful, this could lead to a practical, low-cost way to reduce the risk of type 2 diabetes in women who had gestational diabetes.

What could go wrong

This is a very early, small study (10 participants) focused on designing a strategy, not testing it yet. The actual impact on diabetes prevention remains uncertain.

Conditions

The condition(s) this trial relates to.

Breast Feeding gestational diabetes type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.